Catalyst Wire Dossier Catalyst Wire Dossier

Satralizumab

satralizumab · Chugai Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Satralizumab, covering 2020-12-31 to 2026-08-12. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]

See pricing